News
EHA and TIF explore how COVID-19 is affecting thalassemia and SCD patients
April 20, 2020
Thalassemia patients appeared to fare relatively well after COVID-19 diagnosis in anecdotal series reports from Europe.
News
Pandemic strains blood supply for COVID-19 and noninfected patients
April 16, 2020
“There needs to be a significant call out for people to make every effort to donate blood.”
News
Severe COVID-19 may lower hemoglobin levels
April 15, 2020
The authors suggest that hemoglobin values might provide a prognostic indicator of COVID-19 severity.
News
ASH tackles COVID-19 with hematology-related FAQ, promotes new registries
April 14, 2020
The ASH COVID-19 registries focus on patients with hematological malignancies and sickle cell disease.
News
CDC warns against misuse of opioid-prescribing guideline
April 24, 2019
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing.
News
FDA aims to boost safety of platelets for transfusion
December 20, 2018
The agency is seeking input on ways to decrease the risk of bacterial contamination in platelets stored for 5 and 7 days after collection.
News
In-hospital blood saving strategy appears safe with anemia
December 18, 2018
Tolerating moderate in-hospital anemia did not negatively impact readmissions or mortality over 6 months.
News
Preop anemia management saves blood, costs
November 14, 2018
BOSTON – Managing anemia prior to cardiac surgery saved a hospital more than $100,000 in transfusion costs in a pilot program.
News
Oral iron of no benefit in heart failure with iron deficiency
May 16, 2017
High-dose oral iron therapy doesn’t improve exercise capacity in the estimated 50% of patients with symptomatic heart failure who also have iron deficiency, according to a report published online May 16 in JAMA.Iron deficiency in patients with HF, regardless of their hemoglobin status, is ...
News
PPIs triple heart failure hospitalization risk in atrial fib patients
May 10, 2017
PARIS – Atrial fib patients taking proton pump inhibitors, largely unnecessarily, have a far greater risk of hospitalization for an acute heart failure episode.